Prospera Financial Services »

Outlook Therapeutics shares owned by Prospera Financial Services

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Prospera Financial Services from 13F filings

Historical chart of Prospera Financial Services investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Prospera Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Prospera Financial Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $12k 31k 0.39

More positions owned by Prospera Financial Services

Apple (AAPL)
Microsoft Corporation (MSFT)
First Tr Exchange-traded First Tr Enh New (FTSM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Exchange-traded Dorsey Wrt 5 Etf (FV)
NVIDIA Corporation (NVDA)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Exxon Mobil Corporation (XOM)
First Tr Value Line Divid In SHS (FVD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Procter & Gamble Company (PG)
Blackstone Group Inc Com Cl A (BX)
Vanguard Index Fds Value Etf (VTV)

View all positions for Prospera Financial Services

Top funds holding Outlook Therapeutics

Vanguard Group
Charles Schwab Investment Management
Rosalind Advisors
Scotia Capital
Millennium Management
Bank of America Corporation
Barclays
Rhumbline Advisers
Gables Capital Management
UBS Group
Ancora Advisors
Jpmorgan Chase & Co
Alliancebernstein
American International
Captrust Financial Advisors

View all funds holding Outlook Therapeutics